27.04.2017
- Bioelectronic technologies for modulating the signaling capabilities of the nervous system could pose challenges for producers of medicinal materials and chemicals – but also for...
07.04.2017
- Japan’s Astellas Pharma has agreed to buy privately held Belgian drug developer Ogeda in a transaction worth up to €800 million. The acquisition expands the Tokyo-headquartered...
20.12.2016
- Proteros Biostructures has entered into a second research agreement with Merck Sharp & Dohme (known as MSD outside the US and Canada). The new collaboration is aimed at developing...
06.12.2016
- Despite tremendous challenges facing the pharmaceutical industry, it continues with its commitment to innovation and the discovery of novel drugs to address unmet medical needs...
26.10.2016
- UK drugmaker GlaxoSmithKline (GSK) is collaborating with US life sciences company Fimbrion to develop a first-in-class small molecule drug to treat and prevent urinary tract...
26.09.2016
- Despite tremendous challenges facing the pharmaceutical industry, it continues with its commitment to innovation and the discovery of novel drugs to address unmet medical needs...
16.09.2016
- Cambrex, the leading manufacturer of small molecule innovator and generic Active Pharmaceutical Ingredients (APIs), has announced a SEK 72 million ($9 million) investment to expand...
Growth in the global oncology drug market is an important measure of opportunities in drug development and manufacturing, including for contract manufacturers of active...
